With the passage of the Affordable Care Act in 2010 and most provisions due to take effect in 2014, it’s reasonable to ask what MD Anderson is doing to prepare.
For the seventh straight year, MD Anderson has been ranked No. 1 in cancer care by U.S. News and World Report’s annual “Best Hospitals” survey. During the past 12 years, the institution has ranked first in cancer care 10 times. Since 1990, when the survey began, it’s been listed as one of the top two cancer hospitals in the nation.
Also nationally ranked are three MD Anderson specialties: ear, nose and throat (No. 3), gynecology (No. 6) and urology (No. 43). The institution’s orthopedic, neurosurgery, nephrology, psychiatry and geriatrics services were named as “High Performing” specialties.
MD Anderson continues as one of the largest cancer centers in the world, last year serving more than 115,000 people, nearly one-third of them new patients. Many come to the institution seeking the latest therapies, diagnostics, surgical techniques and prevention strategies.
About 8,500 patients were registered on clinical trials exploring new treatments last year, making it home to the largest clinical trials program for cancer in the nation.
More Stories From Conquest
Creating an umbrella of care
Patients in cancer treatment often have other health issues that can affect treatment and/or quality of life. Over the past 25 years, MD Anderson has added myriad services to handle these conditions while providing quality care for patients.
Seed, soil and metastasis
In 1889, Stephen Paget, an English surgeon and pathologist, hypothesized that metastasis (the spread of cancer) did not occur randomly. It took nearly a century before Isaiah Fidler came along to prove him right.
50 years of educating scientists
As the graduate school celebrates its 50th anniversary, its two leaders assess their first year as deans and look forward to an exciting future.
Understanding epigenetics to develop new therapies
Some might call it fate. Three scientists who started their careers in different parts of the world and come from different scientific disciplines now work together at MD Anderson to develop new treatments for patients.
